Shortcut Navigation:
Terms Used On This Page

Community Meetings Hereditary Breast and Ovarian Cancer Risk – What You Need to Know

When:   Sunday, April 6, 2014
1:00 p.m. - 3:00 p.m.

Where:   Tiferet Bet Israel
1920 Skippack Pike
Blue Bell, PA 19422

Register for this free educational program on understanding hereditary breast and ovarian cancer and who may be at increased genetic risk.

BRCA gene mutations are found in people of different ethnic groups. Yet, 1 in 40 individuals of Ashkenazi Jewish ancestry carries a BRCA mutation.

Download a flyer.

During this free educational program, Rebecca Mueller, MS, CGC, CCRC, of the University of Pennsylvania’s Basser Research Center for BRCA, will help you

  • learn who has an increased risk of carrying a BRCA gene mutation
  • understand the process of genetic counseling and testing
  • discover the criteria for, and insurance coverage of, genetic testing
  • develop strategies for talking about genetic risk and test results with family

About Our Speakers

Ms. Mueller received her masters in genetic counseling from Arcadia University in Glenside, Pa., and is certified in genetic counseling, as well as in clinical research coordination. Becca coordinates the outreach mission of the Basser Research Center for BRCA, which involves developing educational programming and materials, increasing access to education and support, and serving as a liaison to related organizations. Becca also provides cancer genetic counseling to patients in the Cancer Risk Evaluation Program through a telemedicine study. It aims to increase access to cancer genetics services through implementation of telemedicine technology at community hospitals.

Location and Registration Information

The program is free,but we ask that you register by April 2. Walk-ins are welcome. Free parking and refreshments will be provided. Register online or by calling our office at (855) 807-6386.

This program is the result of a partnership between LBBC and the University of Pennsylvania’s Basser Research Center for BRCA. It is made possible by a generous grant from 

Women of Vision